Development of Irinotecan Liposome Armed with Dual-Target Anti-Epidermal Growth Factor Receptor and Anti-Fibroblast Activation Protein-Specific Antibody for Pancreatic Cancer Treatment

Pancreatic cancer is one of the most common causes of death in Taiwan. Previous studies have shown that more than 90% of pancreatic cancer cells presented epidermal growth factor receptor (EGFR) cell marker, and this marker is thought to be important as it is related to activation of cancer cell pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Hung-Jun, Liang, Tien-Li, Chang, Yao-Yuan, Liu, Der-Zen, Fan, Jia-Yu, Roffler, Steve R., Lin, Shyr-Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227843/
https://www.ncbi.nlm.nih.gov/pubmed/35745775
http://dx.doi.org/10.3390/pharmaceutics14061202

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227843/
https://www.ncbi.nlm.nih.gov/pubmed/35745775
http://dx.doi.org/10.3390/pharmaceutics14061202

Ejemplares similares